MJFF's Rapid Response Innovation Awards Hit Mid-2009 With Over $1 Million Funded in High-Risk/High-Reward Approaches to Parkinson's Disease
NEW YORK, June 25 /PRNewswire-USNewswire/ -- As of mid-2009, The Michael J. Fox Foundation for Parkinson's Research has already funded over $1 million in high-risk, high-reward approaches to Parkinson's therapeutic development through its groundbreaking Rapid
Response Innovation Awards . Projects...
RAPAFLO(TM) (silodosin) Provides Rapid and Sustained Benign Prostatic Hyperplasia (BPH) Symptom Relief in as Little as Three Days
- Significant peak urine flow (Qmax) improvements within 2-6 hours of the first dose, according to published data -
CORONA, Calif., May 8 /PRNewswire-FirstCall/ -- RAPAFLO (TM) (silodosin), a new, uniquely selective alpha blocker for the treatment of the signs and symptoms of BPH, produ...
Arrayit to Mass Produce Rapid H1N1 Swine Flu Test Chip
SUNNYVALE, Calif., April 30 /PRNewswire-FirstCall/ -- Arrayit Corporation (OTC Bulletin Board: ARYC), a leading manufacturer of products and services for disease prevention, treatment and cure, announced today that it is developing a microarray-based diagnostic test to detect the H1N1 swine...
CyberKnife Radiosurgery for Lung Cancer Sees Increased Interest and Continued Rapid Growth
SUNNYVALE, Calif., March 2 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY ), a global leader in the field of radiosurgery, announced today significant growth in CyberKnife lung cancer treatments in calendar year 2008. The number of lung cancer patients treated with CyberKnife radi...
MicroPhage Successfully Completes Beta Trial for Rapid MRSA Test
LONGMONT, Colo., Jan. 13 /PRNewswire/ -- A new bacterial identification
test that rapidly identifies MRSA infections moved closer to market with
conclusion of its first multicenter clinical trial, which was announced today
by MicroPhage, Inc., http://www.microphage.com . The company also rep...
Video: Tasigna(R) Demonstrates Rapid Response as Initial Therapy in Life-Threatening Form of Leukemia
Tasigna now shows potential to become the treatment of choice for certain newly diagnosed patients with chronic myeloid leukemia
Two separate studies show rapid
elimination of cancer cells in 96% of Tasigna patients and reduction of abnormal CML protein by six months
CIMZIA(R) (Certolizumab Pegol) Provides Rapid and Sustained Relief from Signs and Symptoms of Rheumatoid Arthritis for Two Years
CIMZIA(R) Data Shows Long-term Improvements in Productivity, Quality of Life and Lessened Fatigue According to Studies Presented at American College of Rheumatology (ACR) Annual Scientific Meeting
SAN FRANCISCO, Oct. 27 /PRNewswire/ -- 5:00 AM PST -- UCB announced
today results from se...
Walter Reed Evaluation Concludes FirstVue(TM) HBSAG Test is Preferred over Other Rapid Tests
FirstVue(TM) HBSAG Test Found to Have Higher Sensitivity and Specificity
than Other Rapid
HBSAG Tests and FirstVue(TM) '...and was the preferred test in all phases of this evaluation'
CORAL SPRINGS, Fla., Oct. 13 /PRNewswire/ -- AT First Diagnostic LLC an
emerging worldwide m...
Michael J. Fox Foundation Funds $1.1 Million for Cutting-Edge Approaches to Parkinson's Disease Under Rapid Response Innovation Awards 2008
$2 million in total funding expected by year's end
NEW YORK, July 29 /PRNewswire-USNewswire/ -- Gene silencing techniques
and induced pluripotent stem cell technology are among the cutting-edge
approaches to Parkinson's drug development funded through The Michael J.
Fox Foundation's Rapid
Cardium's Innercool Therapies Unit Announces Publication of Positive Effects of Early and Rapid Hypothermia Following Heart Attack
SAN DIEGO, April 15 /PRNewswire-FirstCall/ -- Cardium Therapeutics
(Amex: CXM ) and its operating unit InnerCool Therapies announced today that
positive findings from a preclinical study, demonstrating a new and
expanded benefit of early rapid
hyperthermia (cooling) for the potential
Sangamo BioSciences and Sigma-Aldrich Announce Publication of Study Demonstrating Zinc Finger Technology for Rapid Generation of 'Knock-Out' Cell Lines
ZFN Technology has Broad Applications in Research, Drug Development and Therapeutics
ST. LOUIS and RICHMOND, Calif., March 24 /PRNewswire-FirstCall/ --
Sigma-Aldrich Corporation (Nasdaq: SIAL ) and Sangamo BioSciences, Inc.
(Nasdaq: SGMO ) announced today the pub...
IDX899 Demonstrates Rapid and Profound Inhibition of HIV Replication in a Phase I/II Clinical Trial in Treatment-Naive HIV-Infected Patients
CAMBRIDGE, Mass., Feb. 6 /PRNewswire-FirstCall/ -- Idenix
Pharmaceuticals, Inc. (Nasdaq: IDIX ), a biopharmaceutical company engaged
in the discovery and development of drugs for the treatment of human viral
and other infectious diseases, today reported data for IDX899, a
REMICADE-Treated Patients Experienced Rapid and Substantial Improvement in Psoriasis in Critical Regions of Body
Marked Improvement in Four Regions of Body Consistent with Overall PASI Response in REMICADE-Treated Patients
SAN ANTONIO, Feb. 4 /PRNewswire/ -- Data from an integrated analysis of
three randomized, placebo-controlled trials showed patients with moderate
to severe plaque psori...
Pharmasset Announces R7128 Achieves 85% Rapid Virologic Response in a 4-week Combination Study for the Treatment of Chronic Hepatitis C
- 85% of patients achieve undetectable HCV RNA levels following 4 weeks of
treatment with R7128 1500mg and Pegasys(R) plus Copegus(R) with safety and tolerability comparable to placebo - - Conference Call Scheduled for 4:00PM ET Today -
PRINCETON, N.J., Jan. 7 /PRNew...
Cepheid Launches New GeneXpert(R) Tests in Europe for Simultaneous, Rapid Detection of Staphylococcus Aureus and Methicillin Resistant Staphylococcus Aureus
Tests for Skin and Soft Tissue Infection and Blood Culture Extend European Product Line for Healthcare Acquired Infections
SUNNYVALE, Calif., Dec. 4 /PRNewswire-FirstCall/ -- Cepheid (Nasdaq:
CPHD) today announced the European release of Xpert(TM) MRSA/SA-Blood
Cultures (BC) and Xper...
Sugammadex Trials Demonstrate Rapid Recovery from Profound Neuromuscular Blockade During General Anesthesia
SAN FRANCISCO, Oct. 16 /PRNewswire/ -- Sugammadex -- the novel
selective relaxant binding agent (SRBA) being developed by Organon --
demonstrated a faster recovery from profound neuromuscular blockade as
compared to neostigmine in the Phase III pivotal Signal trial.(1) In a
second trial, named...
New Analysis of Study Data Shows That Asacol(R) (Mesalamine) Delivers Rapid Symptom Relief for Ulcerative Colitis Patients
Symptom resolution results based on stringent endpoint of clinical remission is more clinically relevant, beneficial to patients
PHILADELPHIA, Oct. 15 /PRNewswire-FirstCall/ -- An analysis of data to
be presented tomorrow at the American College of Gastroenterology (ACG)
Cepheid Announces Termination of Contract With the Centers for Disease Control and Prevention to Develop Rapid Point of Care Test for Avian Influenza
SUNNYVALE, Calif., Sept. 21 /PRNewswire-FirstCall/ -- Cepheid (Nasdaq:
CPHD) today announced the termination of its contract with the Centers for
Disease Control and Prevention (CDC) for development of a rapid
point-of-care diagnostic to detect influenza viruses A and B, and the H5N1
Oritavancin Demonstrates Potent and Rapid In Vitro Activity Against MRSA, VRE and Other Strains of Resistant Bacteria
CHICAGO, Sept. 19 /PRNewswire/ -- Targanta Therapeutics Corporation
today released detailed data from completed studies comparing the in vitro
activity of its lead antibiotic drug candidate, oritavancin, to that of
other antibiotics against a variety of susceptible and resistant strains of
Hypertension: Journal of the American Heart Association Rapid Access Reports: Hispanics' Hypertension Better Controlled With Equal Access to Care
DALLAS, Sept. 12 /PRNewswire/ -- With equal access to medical care and
medication, Hispanic men and women have as good or greater chance as non-
Hispanics of controlling their high blood pressure. When researchers
studied blood pressure control in Hispanics as part of the ALLHAT
BD Announces FDA 510(K) Submission of Rapid Molecular Test to Identify Patients Carrying Staph Superbug Prior to Surgery
First Molecular Test to Simultaneously Identify Staphylococcus Aureus and Methicillin-Resistant Staphylococcus Aureus from Nasal Specimens
SAN DIEGO, Sept. 11 /PRNewswire-FirstCall/ -- BD Diagnostics, a segment
of BD (Becton, Dickinson and Company) (NYSE: BDX ), announced today that it
CLIA Waiver Submitted for Rapid HIV Test Employs StatSure's 'Barrel' Technology
FRAMINGHAM, Mass., Aug. 14 /PRNewswire-FirstCall/ -- StatSure
Diagnostic Systems, Inc. (OTC Bulletin Board: SSUR - News) is pleased to
announce that its patented, "barrel- test" format for the detection of
antibodies to HIV-1/2 in human whole blood, serum, and plasma has completed
the trials n...
Avian (Bird) Flu: Is There a Role for Rapid Tests?
Michael S. Singer, M.D., Ph.D. Corresponding Editor Harvard Medical School
With human infections of bird flu (avian influenza) reported in Asia and Eastern Europe, public health officials have moved swiftly to develop policies on surveillance, diagnosis, and treatment. The virus in ques...
Point of Care Cardiac Analyzers Yield Rapid Cardiac Marker Results
Helen Londe, M.D. Contributing Editor Clinical guidelines from the disciplines of cardiology and laboratory and emergency medicine have all emphasized the importance of cardiac markers in diagnosing or ruling out acute myocardial infarction. The measurement of cardiac troponins is especially usef...
Radius' Investigational Bone Anabolic Agent, BA058, Increased Bone Mineral Density (BMD) at Key Fracture Sites in Phase 2 Clinical Trial in Postmenopausal Osteoporosis
... O'Dea, MD, Chief Medical Officer of Radius. "The greater and faster accrual of BMD with BA058 may allow for shorter durations of treatment and a more rapid
reduction in fracture risk in the severe osteoporotic postmenopausal population, which would be a significant advance in the treatment of this debilit...
Telik Announces Publication of Positive Phase 1 Results of a Multicenter Study of Ezatiostat Hydrochloride (TELINTRA(R), TLK199) Tablets In Patients With Myelodysplastic Syndrome
... non-small cell lung cancer. Telik's product candidates were discovered using its proprietary drug discovery technology, TRAP((R)), which enables the rapid
and efficient discovery of small molecule drug candidates.
TELIK, the Telik logo, TELINTRA, TELCYTA and TRAP are trademarks or registered trade...
Researchers Create First Targeted Knockout Rats Using Zinc Finger Nuclease Technology
...hat ZFN technology bypasses the current need to conduct cumbersome experiments involving nuclear transfer (cloning) or embryonic stem cells and allows rapid
creation of new animal models."
In the study published in Science titled "Knockout Rats via Embryo Microinjection of Zinc Finger Nucleases,...
UPDATE: US Oncology Research Network Participates in Phase III Follow-up Study to BiPar's Investigational Cancer Drug BSI-201
...reast cancer," says Dr. O'Shaughnessy. "We expect that accrual will be very rapid
within the US Oncology network and hope that this trial will lead to rapid
FDA approval of what appears so far to be a well tolerated and effective th...
Human Genome Sciences and GlaxoSmithKline Announce Positive Phase 3 Study Results for BENLYSTA(TM) in Systemic Lupus Erythematosus
...linical development pipeline includes novel drugs to treat hepatitis C, lupus, inhalation anthrax and cancer.
The Company's primary focus is rapid
progress toward the commercialization of its two lead drugs, Albuferon(R) (albinterferon alfa-2b) for hepatitis C and BENLYSTA(TM) (belimumab, formerl...
USC Keck School of Medicine's Dr. Alan Epstein Receives Prestigious National Cancer Institute RAID Award for Breakthrough IL-2 Molecule Therapeutic
...day announced that Dr. Alan Epstein of the USC Keck School of Medicine has received approval for a $3.5 million drug development project through the rapid
Access to Intervention Development (RAID) program of the National Cancer Institute (NCI) for his breakthrough Interleukin-2 (IL-2) cytokine immunother...
Procter & Gamble Pharmaceuticals Launches Asacol(R) HD (mesalamine) Delayed-Release Tablets
...ne Asacol HD 800 mg tablet has not been shown to be bioequivalent to two Asacol 400 mg tablets.
In addition, Asacol HD at 4.8 g/day demonstrated rapid
improvement in rectal bleeding and stool frequency. At three weeks, rectal bleeding improved in 78 percent and 75 percent of the patients in the ASCE...
UNT Health Science Center's Groundbreaking Research Applied to Protecting Brain After Traumatic Injury
...cience Center at Fort Worth have determined that rapid
estrogen administration can protect the brain foll... these animal studies of the protective effects of rapid
estrogen treatment to human patients with severe t....
"Our animal research has demonstrated that rapid
estrogen intervention protects the brain following...
ThromboGenics and BioInvent Start Recruitment of Second 100 Patient Cohort in Phase II DVT Prophylaxis Study With TB-402
...ting properties of this novel long-acting anticoagulant."
Svein Mathisen, CEO of BioInvent, also commented, "We are pleased that
there has been rapid
progress in this study and that the efficacy and safety
monitoring board unanimously recommended that we proceed to a higher dose of
TB-402. It is tes...
Accumetrics, Inc. Announces GRAVITAS Trial 50 Percent Enrolled
...es by providing industry-leading and widely accessible diagnostic tests for rapid
platelet function assessment.
Accumetrics' VerifyNow System is the first rapid
and easy to use platform for measuring an individual's response to multiple...
Cephalon Submits NUVIGIL Supplemental New Drug Application for the Treatment of Excessive Sleepiness Associated with Jet Lag Disorder
...ulting from eastbound travel. Jet lag disorder is an acute condition that occurs when a person's internal body clock becomes disrupted as a result of rapid
travel across several time zones. Based on U.S. Bureau of Labor Statistics findings, an estimated 70 million American travelers experience jet lag an...
Sangamo BioSciences Announces Achievement of Key Milestone in Cell Engineering Agreement With Genentech
... Phil., Sangamo's vice president of research. "Moreover, the efficiency of this approach obviates the need for selection markers, thereby enabling the rapid
generation of cell lines in which multiple genes have been knocked out. Our proven ability to quickly and selectively knock out multiple genes in the...
Data Demonstrates Long-Term Reduction In Seizure Frequency With Novel Once Daily Anti-Epileptic Zebinix(R)
Eslicarbazepine acetate (ESL) is a novel once-daily voltage-gated sodium
channel blocker designed to selectively inhibit the rapid
firing of nerve
cells that causes seizures. It specifically targets the inactivated state of
the ion channel, preventing its return to the active stat...
Sosei and Vectura Announce Start of Phase III Clinical Study With NVA237
...tment of chronic obstructive pulmonary disease
(COPD). NVA237 is a dry powder formulation for oral inhalation of
glycopyrronium bromide, a LAMA with a rapid
onset of activity. The study has
now appeared on clinicaltrials.gov and will be recruiting in the next few
weeks when the first patient first visit wi...
West Wireless Health Institute Teams with Corventis for its First Multicenter, Randomized Clinical Trial
...monitoring. Through innovative wireless sensor technologies that use smartphones and broadband communication, we have the new capability of early and rapid
detection of key parameters with a simple disposable smart 'band aid' that can relay the data on a continuous basis through the Internet."
Great Basin Scientific, Inc. Raises $3.6 Million in Bridge Funding to Prepare for Launch of First Product
...es company that commercializes breakthrough technologies for the molecular, rapid
diagnostic testing market. The company is dedicated to development of simpl...improve automation, throughput, scalability, reliability and ease of use of rapid
diagnostic testing for point-of-care settings such as physician's office la...